High-throughput viable circulating tumor cell isolation using tapered-slit membrane filter-based chipsets in the differential diagnosis of ovarian tumors
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304704 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Nam Kyeong Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Cell Separation, Ovarian Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy.
Abstract (Originalsprache)
Objective
To evaluate the diagnostic performance of circulating tumor cells (CTCs) using tapered-slit membrane filter (TSF)-based chipsets for the differential diagnosis of adnexal tumors.
Methods
A total of 230 women with indeterminate adnexal tumors were prospectively enrolled. The sensitivity, specificity, and accuracy of the CTC-detecting chipsets were analyzed according to postoperative pathological results and compared with those of cancer antigen (CA)-125 and imaging tests.
Results
Eighty-one (40.3%) benign tumors, 31 (15.4%) borderline tumors, and 89 (44.3%) ovarian cancers were pathologically confirmed. The sensitivity, specificity, and accuracy of CTC-detecting chipsets (75.3%, 58.0%, and 67.1%) for differentiating ovarian cancer from benign tumors were similar to CA-125 (78.7%, 53.1%, and 66.5%), but lower than CT/MRI (94.2%, 77.9%, and 86.5%). “CTC or CA125” showed increased sensitivity (91.0%) and “CTC and CA-125” revealed increased specificity (77.8%), comparable to CT/MRI. CTC detection rates in stage I/II and stage III/IV ovarian cancers were 69.6% and 81.4%, respectively. The sensitivity to detect high-grade serous (HGS) cancer from benign tumors (84.6%) was higher than that to detect non-HGS cancers (68.0%).
Conclusion
Although the diagnostic performance of the TSF platform to differentiate between ovarian cancer and benign tumors did not yield significant results, the combination of CTC and CA-125 showed promising potential in the diagnostic accuracy of ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
- Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.
- Cell Bench Research Center, Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.
ORCID-Profile: Yong Beom Kim, Young-Ho Cho
Förderung
- Ministry of Trade, Industry and Energy
Zitieren
APA
Kim, N. K., Suh, D. H., Kim, K., No, J. H., Kim, Y. B., Kim, M., & Cho, Y. H. (2024). High-throughput viable circulating tumor cell isolation using tapered-slit membrane filter-based chipsets in the differential diagnosis of ovarian tumors. PLOS ONE. https://doi.org/10.1371/journal.pone.0304704
Vancouver
Kim NK, Suh DH, Kim K, No JH, Kim YB, Kim M, et al. High-throughput viable circulating tumor cell isolation using tapered-slit membrane filter-based chipsets in the differential diagnosis of ovarian tumors. PLOS ONE. 2024. doi:10.1371/journal.pone.0304704
BibTeX
@article{Kim2024,
author = {Kim, Nam Kyeong and Suh, Dong Hoon and Kim, Kidong and No, Jae Hong and Kim, Yong Beom and Kim, Minki and Cho, Young-Ho},
title = {High-throughput viable circulating tumor cell isolation using tapered-slit membrane filter-based chipsets in the differential diagnosis of ovarian tumors},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304704}
}
EUVIMED